Rockville, MD, United States of America

Kazuyuki Taga


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuyuki Taga: Innovator in Viral Replication Inhibition

Introduction

Kazuyuki Taga is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of virology, particularly in methods to inhibit viral replication. His work is crucial in the ongoing battle against viral infections, including HIV.

Latest Patents

Kazuyuki Taga holds a patent titled "Methods of inhibiting viral replication using IL-10." This invention provides a method for inhibiting the replication of human immunodeficiency virus (HIV) in infected cells by administering a replication-inhibiting amount of interleukin-10. The patent also outlines a parenteral method for administering interleukin-10. Additionally, it describes a method for inhibiting retroviral replication in human subjects infected by retroviruses, as well as a method for treating Kaposi's sarcoma through effective doses of interleukin-10.

Career Highlights

Taga is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing therapeutic strategies against viral infections. His innovative approaches have the potential to improve treatment outcomes for patients suffering from HIV and related conditions.

Collaborations

Kazuyuki Taga has collaborated with esteemed colleagues such as Robert Yarchoan and M Wayne Saville. These partnerships have fostered a collaborative environment that enhances research and development in the field of viral replication inhibition.

Conclusion

Kazuyuki Taga's contributions to the field of virology through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future research in viral treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…